A phase I trial on the intra- and post-operative intracranial administration of ipilimumab and nivolumab in patients with recurrent high-grade glioma.

被引：0
|
作者：
Neyns, Bart
Dirven, Iris
Lescrauwaet, Louise
Del'haye, Jacomi
Geens, Wietse
Geeraerts, Xenia
Stevens, Latoya
Brock, Stefanie
Kockx, Mark
Seynaeve, Laura
Everaert, Hendrik
Vanbinst, Anne-Marie
Tuyaerts, Sandra
Duerinck, Johnny
机构：
[1] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel UZ Brussel, Brussels, Belgium
[2] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel UZ Brussel, Dept Med Oncol, Brussels, Belgium
[3] Univ Ziekenhuis Brussel UZ Brussel, Brussels, Belgium
[4] CellCarta, Antwerp, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2037
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.
    Lee, Eudocia Quant
    Muzikansky, Alona
    Gerstner, Elizabeth Robins
    Kuhn, John G.
    Reardon, David A.
    Nayak, Lakshmi
    Norden, Andrew David
    Doherty, Lisa M.
    Rifenburg, Jennifer
    LaFrankie, Debra C.
    Pulverenti, Julee
    Vardam-Kaur, Trupti
    Stokes, Deirdre
    Smith, Katrina Howard
    McCluskey, Christine Sceppa
    Gaffey, Sarah C.
    Batchelor, Tracy
    Duda, Dan G.
    Jain, Rakesh K.
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.
    Peters, Katherine B.
    Archer, Gerald E.
    Norberg, Pamela
    Xie, Weihua
    Threatt, Stevie
    Lipp, Eric S.
    Herndon, James Emmett
    Healy, Patrick
    Congdon, Kendra
    Sanchez-Perez, Luis
    Friedman, Henry S.
    Desjardins, Annick
    Vlahovic, Gordana
    Sampson, John H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] A phase II trial of sunitinib in patients with recurrent high-grade glioma
    Chaskis, C.
    Sadones, J.
    Michotte, A.
    Dujardin, M.
    Everaert, H.
    Neyns, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Phase I study of terameprocol in patients with recurrent high-grade glioma
    Grossman, Stuart A.
    Ye, Xiaobu
    Peereboom, David
    Rosenfeld, Myrna R.
    Mikkelsen, Tom
    Supko, Jeffrey G.
    Desideri, Serena
    NEURO-ONCOLOGY, 2012, 14 (04) : 511 - 517
  • [5] A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF AUTOLOGOUS CD1C(BDCA-1)+ /CD141(BDCA-3)+ MYELOID DENDRITIC CELLS IN COMBINATION WITH IPILIMUMAB AND NIVOLUMAB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA
    Duerinck, J.
    Lescrauwaet, L.
    Dirven, I
    Del'haye, J.
    Cammaert, M.
    Geens, W.
    Geeraerts, X.
    Stevens, L.
    Brock, S.
    Kockx, M.
    Everaert, H.
    Vanbinst, A.
    Tuyaerts, S.
    Neyns, B.
    NEURO-ONCOLOGY, 2024, 26 : V17 - V17
  • [6] Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
    Franceschi, E
    Cavallo, G
    Scopece, L
    Paioli, A
    Pession, A
    Magrini, E
    Conforti, R
    Palmerini, E
    Bartolini, S
    Rimondini, S
    Esposti, RD
    Crinó, L
    BRITISH JOURNAL OF CANCER, 2004, 91 (06) : 1038 - 1044
  • [7] Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
    E Franceschi
    G Cavallo
    L Scopece
    A Paioli
    A Pession
    E Magrini
    R Conforti
    E Palmerini
    S Bartolini
    S Rimondini
    R Degli Esposti
    L Crinò
    British Journal of Cancer, 2004, 91 : 1038 - 1044
  • [8] Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
    Neyns, B.
    Sadones, J.
    Joosens, E.
    Bouttens, F.
    Verbeke, L.
    Baurain, J. -F.
    D'Hondt, L.
    Strauven, T.
    Chaskis, C.
    Veld, P. In't
    Michotte, A.
    De Greve, J.
    ANNALS OF ONCOLOGY, 2009, 20 (09) : 1596 - 1603
  • [9] A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF INCREASING DOSES OF IPILIMUMAB PLUS FIXED DOSE NIVOLUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGB)
    Geens, Wietse
    Schwarze, Julia Katharina
    Tijtgat, Jens
    Lescrauwaet, Louise
    Tuyaerts, Sandra
    Geeraerts, Xenia
    Stevens, Latoya
    Vanbinst, Anne-Marie
    Everaert, Hendrik
    Bruneau, Michael
    Duerinck, Johnny
    Neyns, Bart
    NEURO-ONCOLOGY, 2022, 24 : 62 - 62
  • [10] Repeated intracranial administration of ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial
    Geens, W.
    Schwarze, J. K.
    Awada, G.
    Tijtgat, J.
    Lescrauwet, L.
    Geeraerts, X.
    Vaeyens, F.
    Cras, L.
    Van Binst, A.
    Everaert, H.
    Michotte, A.
    Cauwenbergh, T.
    Bruneau, M.
    Forsyth, R.
    Tuyaerts, S.
    Neyns, B.
    Duerinck, J.
    NEURO-ONCOLOGY, 2022, 24
12345